21146 ⎘
Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
Sub-classes:COMPOSITIONS FOR AND METHODS OF TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASE TYPE VI AND TYPE IX
#2COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE
#3ALLOGENEIC HUMAN PLASMA AND PLATELET DERIVED PRODUCTS AND USES THEREOF
#4METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#5Clazakizumab in the Treatment of Chronic Antibody-Mediated Rejection of Organ Transplant
#6MULTIVITAMIN FOR ADJUVANT TREATMENT OF TUMOR, AND PREPARATION METHOD AND APPLICATION THEREOF
#7TREATMENT OF STAPHYLOCOCCUS RELATED DISEASES
#8TREATMENT WITH HIGHLY SIAYLATED IGG COMPOSITIONS
#9ANTAGONISTS OF THE COMPLEMENT SYSTEM FOR USE IN METHODS OF TREATING PARAPROTEINEMIC NEUROPATHIES
#10COMPOSITIONS FOR AND METHODS OF TREATING AND/OR PREVENTING GLUTARIC ACIDURIA TYPE-1
#11TREATMENT OF INTESTINAL LUMEN IMMUNOGLOBULIN DEFICIENCY WITH SEMISYNTHETIC POLYCLONAL HUMAN SECRETORY IMMUNOGLOBIN A
#12DSG2 COMPOSITIONS AND METHODS
#13MODIFIED TNF AS A CAPTURE LIGAND
#14ANTI-INFLAMMATORY, NON-FUCOSYLATED IMMUNOGLOBULIN PREPARATION AND PRODUCTION METHOD THEREFOR
#15METHODS OF TUMOUR THERAPY WITH A COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES
#16INFANT FORMULA
#17Autologous Cancer Vaccines
#18Catechol Nanoparticle, Catechol Protein Nanoparticle, and Preparation Method and Use Thereof
#19Sialylated Glycoproteins
#20COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY
#21THERAPIES AND METHODS TO TREAT TLR2-MEDIATED DISEASES AND DISORDERS
#22COMPOSITIONS AND METHODS FOR THE PREVENTION OF TYPE I HYPERSENSITIVITY REACTIONS
#23EPIDERMAL GROWTH FACTOR-LIKE 7 PEPTIDE AND USES THEREOF
#24Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
#25Modified TNF as a capture ligand
#26Compositions and methods for the treatment of immunodeficiency
#27Methods of treating Kawasaki disease
#28Monoclonal Antibodies to ELTD1 and Uses Thereof
#29CLAZAKIZUMAB IN THE TREATMENT OF CHRONIC ANTIBODY-MEDIATED REJECTION OF ORGAN TRANSPLANT
#30Conditioning regimens and methods for inducing mixed chimerism
#31METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING ACUTE EXACERBATIONS WITH POLYCLONAL IMMUNOGLOBULIN
#32TREATMENT WITH HIGHLY SILYLATED IGG COMPOSITIONS
#33IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES
#34Compositions and methods for treating Pompe disease
#35TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G
#36Therapies and methods to treat TLR2-mediated diseases and disorders
#37Compositions and methods for the treatment of immunodeficiency
#38Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
#39Autologous cancer vaccines
#40Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases
#41IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES
#42Methods of treating Kawasaki Disease
#43Compositions and methods for treating arenavirus infection
#44Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
#45TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G
#46Sialylated glycoproteins
#47Conditioning regimens and methods for inducing mixed chimerism
#48IgG stimulated remyelination of peripheral nerves
#49Compositions and methods for the treatment of immunodeficiency
#50Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
#51Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof
#52Compositions and methods for the treatment of immunodeficiency
#53Methods for Treating HIV-Associated Enteropathy Symptoms With Immunoglobulin/Protein Isolate
#54Method for the preparation of immunoglobulins
#55Method and system for treating patients with alzheimer disease
#56Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#57Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
#58Compositions and methods for the treatment of immunodeficiency
#59Compositions and methods for the treatment of immunodeficiency
#60Composition with reduced immunogenicity
#61PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF BURNOUT SYNDROME
#62Methods and compositions for treating associated disease
#63IGM THERAPY IN PREVENTION OF ONSET, PROGRESSION, AND RECURRENCE OF AUTOIMMUNE TYPE 1 DIABETES
#64IgG stimulated remyelination of peripheral nerves
#65Combination therapy using immunoglobulin and C1-Inhibitor
#66USE OF GOAT SERUM FOR VETERINARY TREATMENT
#67IgG stimulated remyelination of peripheral nerves
#68TREATMENT OF MS WITH GOAT SERUM
#69TREATMENT OF DISEASES
#70PLASMA-DERIVED IMMUNOGLOBULIN FOR USE IN THE TREATMENT AND PREVENTION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS)
#71COLD TREATMENT
#72Use of goat serum for veterinary treatment
#73Use a goat serum for veterinary treatment
#74Treatment of MS with goat serum
#75Method of Treating Cancer with Immunomodulatory Compounds and IgG
#76Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
#77Use of goat serum for veterinary treatment
#78Immunoglobulin and fatty acids
#79Treatment of Diseases
#80POLYPEPTIDES WITH ENHANCED ANTI-INFLAMMATORY AND DECREASED CYTOTOXIC PROPERTIES AND RELATING METHODS
#81Use of Goat Serum for Veterinary Treatment
#82Modified antibody variable domains
#83Compositions and methods for the treatment of immunodeficiency